Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: The Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol. 2001;132:668–81.
Kim KL, Joo K, Park SJ, Park KH, Woo SJ. Progression from intermediate to neovascular age-related macular degeneration according to drusen subtypes: Bundang AMD cohort study report 3. Acta Ophthalmol. 2022;100:e710–e8.
Baek J, Lee JH, Chung BJ, Lee K, Lee WK. Choroidal morphology under pachydrusen. Clin Exp Ophthalmol. 2019;47:498–504.
Spaide RF, Curcio CA. Drusen characterization with multimodal imaging. Retina. 2010;30:1441–54.
Ferris FL, Davis MD, Clemons TE, Lee LY, Chew EY, Lindblad AS, et al. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol. 2005;123:1570–4.
Ferris FL 3rd, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, et al. Clinical classification of age-related macular degeneration. Ophthalmology. 2013;120:844–51.
Spaide RF. Disease expression in nonexudative age-related macular degeneration varies with choroidal thickness. Retina. 2018;38:708–16.
Sato-Akushichi M, Kinouchi R, Ishiko S, Hanada K, Hayashi H, Mikami D, et al. Population-based prevalence and 5-Year change of soft drusen, pseudodrusen, and pachydrusen in a Japanese population. Ophthalmol Sci. 2021;1:100081.
Cheung CMG, Gan A, Yanagi Y, Wong TY, Spaide R. Association between choroidal thickness and drusen subtypes in age-related macular degeneration. Ophthalmol Retina. 2018;2:1196–205.
Lee J, Choi S, Lee CS, Kim M, Kim SS, Koh HJ, et al. Neovascularization in fellow eye of unilateral neovascular age-related macular degeneration according to different drusen types. Am J Ophthalmol. 2019;208:103–10.
Fukuda Y, Sakurada Y, Yoneyama S, Kikushima W, Sugiyama A, Matsubara M, et al. Clinical and genetic characteristics of pachydrusen in patients with exudative age-related macular degeneration. Sci Rep. 2019;9:11906.
Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146:496–500.
Lee MY, Yoon J, Ham DI. Clinical characteristics of reticular pseudodrusen in Korean patients. Am J Ophthalmol. 2012;153:530–5.
Balaratnasingam C, Cherepanoff S, Dolz-Marco R, Killingsworth M, Chen FK, Mendis R, et al. Cuticular drusen: Clinical phenotypes and natural history defined using multimodal imaging. Ophthalmology. 2018;125:100–18.
Spaide RF, Jaffe GJ, Sarraf D, Freund KB, Sadda SR, Staurenghi G, et al. Consensus nomenclature for reporting neovascular age-related macular degeneration data: Consensus on neovascular age-related macular degeneration nomenclature study group. Ophthalmology. 2020;127:616–36.
Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology. 1991;98:1128–34.
Wang JJ, Foran S, Smith W, Mitchell P. Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: The Blue Mountains Eye Study cohort. Arch Ophthalmol. 2003;121:658–63.
Teo KYC, Cheong KX, Ong R, Hamzah H, Yanagi Y, Wong TY, et al. Macular neovascularization in eyes with pachydrusen. Sci Rep. 2021;11:7495.
Diniz B, Ribeiro RM, Rodger DC, Maia M, Sadda S. Drusen detection by confocal aperture-modulated infrared scanning laser ophthalmoscopy. Br J Ophthalmol. 2013;97:285–90.
Ooto S, Ellabban AA, Ueda-Arakawa N, Oishi A, Tamura H, Yamashiro K, et al. Reduction of retinal sensitivity in eyes with reticular pseudodrusen. Am J Ophthalmol. 2013;156:1184–91.e2.
van de Ven JP, Smailhodzic D, Boon CJ, Fauser S, Groenewoud JM, Chong NV, et al. Association analysis of genetic and environmental risk factors in the cuticular drusen subtype of age-related macular degeneration. Mol Vis. 2012;18:2271–8.
Cohen SY, Dubois L, Tadayoni R, Delahaye-Mazza C, Debibie C, Quentel G. Prevalence of reticular pseudodrusen in age-related macular degeneration with newly diagnosed choroidal neovascularisation. Br J Ophthalmol. 2007;91:354–9.
Kong M, Kim S, Ham DI. Incidence of late age-related macular degeneration in eyes with reticular pseudodrusen. Retina. 2019;39:1945–52.
Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. Lancet Glob Health. 2014;2:e106–16.
Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology. 1995;102:1450–60.
Klein R, Klein BEK, Linton KLP. Prevalence of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology. 2020;127:S122–S32.
Lee J, Byeon SH. Prevalence and clinical characteristics of pachydrusen in polypoidal choroidal vasculopathy: Multimodal image study. Retina. 2019;39:670–8.
Lee JH, Kim JY, Jung BJ, Lee WK. Focal disruptions in ellipsoid zone and interdigitation zone on spectral-domain optical coherence tomography in pachychoroid pigment epitheliopathy. Retina. 2019;39:1562–70.
Keenan TD, Agrón E, Domalpally A, Clemons TE, van Asten F, Wong WT, et al. Progression of geographic atrophy in age-related macular degeneration: AREDS2 Report Number 16. Ophthalmology. 2018;125:1913–28.